Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 403
Selected: 0
NCT IDTitle
NCT00276614Bortezomib in Treating Patients With Metastatic Kidney Cancer
NCT01144247Cellular Immunotherapy Study for Brain Cancer
NCT06568016A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
NCT00022334Vaccine Therapy in Treating Patients With Liver Cancer
NCT00004889Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
NCT02048020Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
NCT00345826Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
NCT00005617Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma
NCT04106362Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma
NCT00098462Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT07323641Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
NCT06059690Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
NCT00003143Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
NCT00324597AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT06090630MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
NCT03515577Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery
NCT03902951Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
NCT00004194Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease
NCT00104767Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT03953157Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
NCT00033527INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer
NCT00005083Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00612066Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
NCT00088946Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
NCT00022321Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
NCT05688215Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
NCT0373235218F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
NCT00093704Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
NCT00040950Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00138164Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00335868PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
NCT03386071Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib
NCT04305925Focal Laser Ablation of Prostate Cancer
NCT07310004Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies
NCT00084747Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
NCT00601289Temozolomide in Treating Patients With Invasive Pituitary Tumors
NCT00024310Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT05950113CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT04765150Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
NCT06075589Psychoeducation for Uveal Melanoma
NCT03503643Hemi-Gland Cryoablation for Prostate Cancer at UCLA
NCT06090916Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer
NCT00040989BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
NCT00346372Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
NCT03892720Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer
NCT03128619Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer
NCT07118176Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT03601455Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer
NCT00004132Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
NCT06225011Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer